Patents Assigned to Arcaris, Inc.
-
Publication number: 20030049599Abstract: The present invention relates to a method for performing negative selections—i.e., identifying agents that can eliminate a cell from a population. More specifically, the invention relates to a method using oligonucleotides covalently linked to a solid support, such as beads, to isolate specific labeled nucleic acid sequences that encode agents which kill or arrest growth in a cell.Type: ApplicationFiled: January 18, 2002Publication date: March 13, 2003Applicant: Arcaris, Inc.Inventor: C. Alexander Kamb
-
Publication number: 20020172965Abstract: The present invention relates to a method for the comparative assessment of the level of specific nucleic acid sequences in samples derived from different sources. More specifically, the invention relates to a method using oligonucleotides covalently linked to a solid support, such as beads, to isolate specific labeled nucleic acid sequences from complex mixtures. The methods disclosed allow quantitative comparisons of the amount of nucleic acid of defined sequence in a plurality of different samples of nucleic acid, e.g., from different cells or tissues or from genetic libraries. Nucleic acids from the samples are labeled in such a fashion that the signals can be distinguished and compared following hybridization to the oligonucleotides on the beads. According to the invention, the solid supports with the hybridized nucleic acid may be retrieved, and the target nucleic acid eluted and analyzed.Type: ApplicationFiled: February 1, 2002Publication date: November 21, 2002Applicant: Arcaris, Inc.Inventors: Carl Alexander Kamb, Michael John Feldhaus
-
Publication number: 20020132229Abstract: The present invention is directed to selection systems for the identification, by functional analysis, of cell proliferation genes that are involved in viral growth and viral disease. The invention also includes methods for identifying perturbagens and cellular targets that are involved in viral growth and viral disease.Type: ApplicationFiled: August 14, 2001Publication date: September 19, 2002Applicant: Arcaris, Inc.Inventors: Carl Alexander Kamb, Mark A. Poritz
-
Publication number: 20020031790Abstract: Generally applicable methods for using phenotypic probes to reduce or eliminate false positives, and thereby identify physiologically relevant endogenous target molecules, are provided. The methods use both protein interaction assay steps and phenotypic assay steps. In some embodiments, protein interactions are detected utilizing yeast two hybrid techniques.Type: ApplicationFiled: July 17, 2001Publication date: March 14, 2002Applicant: ARCARIS, INC.Inventor: Carl Alexander Kamb
-
Publication number: 20020019005Abstract: The present invention is directed to selection systems for the identification of cell proliferation genes based on functional analysis. More specifically, the invention is directed to a process for the identification of a cell proliferation promoting activity, the isolation of genes involved in such cell proliferation promoting activity, and the use of the so identified genes for the diagnosis or treatment of a disease associated with excessive cell proliferation. The invention further is directed to the design and development of antibodies, peptides, nucleic acids, and other compounds which specifically interfere with the function of the identified gene and/or its gene product, and pharmaceutical compositions comprising such compounds, for the treatment of diseases associated with inappropriate or unregulated cell proliferation.Type: ApplicationFiled: August 2, 2001Publication date: February 14, 2002Applicant: Arcaris, Inc.Inventor: Carl Alexander Kamb
-
Patent number: 6060240Abstract: The present invention relates to a method for the comparative assessment of the level of specific nucleic acid sequences in samples derived from different sources. More specifically, the invention relates to a method using oligonucleotides covalently linked to a solid support, such as beads, to isolate specific labeled nucleic acid sequences from complex mixtures. The methods disclosed allow quantitative comparisons of the amount of nucleic acid of defined sequence in a plurality of different samples of nucleic acid, e.g., from different cells or tissues or from genetic libraries. Nucleic acids from the samples are labeled in such a fashion that the signals can be distinguished and compared following hybridization to the oligonucleotides on the beads. According to the invention, the solid supports with the hybridized nucleic acid may be retrieved, and the target nucleic acid eluted and analyzed.Type: GrantFiled: December 13, 1996Date of Patent: May 9, 2000Assignee: Arcaris, Inc.Inventors: Alexander Kamb, Michael John Feldhaus
-
Patent number: 6025485Abstract: Methods and compositions for peptides or protein fragments displayed on scaffolds and libraries of sequences encoding peptides or protein fragments displayed on scaffolds that permit the properties of the library to be easily and quantitatively monitored are disclosed. The scaffold is a protein that is capable of emitting light. Thus, analysis of the expression of individual members of the library when they are expressed in cells may be carried out using instruments that can analyze the emitted light, such as flow sorter (FACS), a spectrophotometer, a microtitre plate reader, a CCD, a fluorescence microscope, or other similar device. This permits screening of the expression library in host cells on a cell-by-cell basis, and enrichment of the library for sequences that have predetermined characteristics.Type: GrantFiled: November 6, 1997Date of Patent: February 15, 2000Assignee: Arcaris, Inc.Inventors: Carl Alexander Kamb, Majid Abedi
-
Selection systems and methods for identifying genes and gene products involved in cell proliferation
Patent number: 5998136Abstract: The present invention is directed to selection systems for the identification of cell proliferation genes based on functional analysis. More specifically, the invention is directed to a process for the identification of a cell proliferation promoting activity, the isolation of genes involved in such cell proliferation promoting activity, and the use of the so identified genes for the diagnosis or treatment of a disease associated with excessive cell proliferation. The invention further is directed to the design and development of antibodies, peptides, nucleic acids, and other compounds which specifically interfere with the function of the identified gene and/or its gene product, and pharmaceutical compositions comprising such compounds, for the treatment of diseases associated with inappropriate or unregulated cell proliferation.Type: GrantFiled: August 19, 1996Date of Patent: December 7, 1999Assignee: Arcaris, Inc.Inventor: Carl Alexander Kamb -
Patent number: 5955275Abstract: Methods for identifying nucleic acid sequences that affect a cellular phenotype are disclosed. The method uses a reporter gene whose level of expression correlates with the phenotype in conjunction with a method or device for measuring the level of reporter expression. An expression library is introduced into the cells, and those cells exhibiting changes in reporter expression level are selected. Expression library inserts from the selected cells are isolated, thereby providing a sub-library enriched for sequences that affect the phenotype reflected by the reporter. Further rounds of sub-library introduction and cell selection may be carried out to provide additional enrichment Sequences identified using this method may be used to ascertain the identity of additional molecules involved in generating the cellular phenotype.Type: GrantFiled: March 4, 1997Date of Patent: September 21, 1999Assignee: Arcaris, Inc.Inventor: Carl Alexander Kamb